发明名称 Compositions for inhibiting immune complex formation in a subject
摘要 Polypeptides and other compounds that can bind specifically to the CH2-CH3 cleft of an immunoglobulin molecule, and methods for using such polypeptides and compounds to inhibit Fc-mediated immune complex formation, are described.
申请公布号 US9447145(B2) 申请公布日期 2016.09.20
申请号 US201313751428 申请日期 2013.01.28
申请人 Trinity Therapeutics, Inc. 发明人 Bodie Neil M.;Altman Elliot
分类号 C07K7/08;C07K14/47;A61K38/00 主分类号 C07K7/08
代理机构 Fish & Richardson P.C. 代理人 Fish & Richardson P.C.
主权项 1. A composition comprising a pharmaceutically acceptable carrier and a polypeptide that comprises the amino acid sequence Cys-Ala-Xaa-His-Leu-Gly-Glu-Leu-Val-Trp-Cys-Thr (SEQ ID NO:8), wherein the Xaa in SEQ ID NO:8 is Trp, Tyr, or Phe, wherein administration of said composition to a subject in need thereof reduces immune complex formation in said subject, wherein the polypeptide further comprises a terminal stabilizing group at the amino-terminal end, wherein the terminal stabilizing group is a tripeptide having the amino acid sequence Xaa-Pro-Pro, wherein the Xaa in the terminal stabilizing group is any amino acid, and wherein the terminal stabilizing group facilitates survival of the polypeptide in vivo.
地址 Agoura Hills CA US